Company Profile

Company Overview

We believe in an equitable world, where there is a simple path that takes medicines to those who need them most. We’re revolutionizing the way medicines are discovered and brought to people. EQRx is launching to create novel, patent-protected medicines at prices that are more affordable for people and sustainable for healthcare systems. A first of its kind biotechnology company, EQRx is focused on re-engineering the process from drug discovery to patient delivery with the goal of offering a market-based solution for the rising cost of medicines. Leveraging advances in science and technology to bring treatments for life threatening and chronic diseases to people more efficiently and cost-effectively, EQRx intends to offer its therapies at dramatically lower prices compared to today’s innovative medicines.

“Over the last several decades, society has benefited from unprecedented technological advances and a deeper understanding of disease biology, revolutionizing the way many diseases are treated today. That said, the pricing of new therapeutic approaches is pushing beyond the limits of common sense, preventing people and society from equally benefiting from innovation,” said Alexis Borisy, chairman and chief executive officer of EQRx. “The time is now for a market-based solution to rising drug costs. Our blue-chip team of founders and leaders is proud to launch EQRx and to lead the way in redefining what it means to innovate and deliver high-quality medicines that are within reach of people through more equitable prices.”